Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes.
Exploring the potential of public proteomics data.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
A salty taste to autoimmunity.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
FDA Approves New Drug to Treat Psoriasis
Brain stem and cerebellar atrophy in chronic progressive neuro-Behçet's disease.
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Prolactin in multiple sclerosis.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.

Pages